Journal of Clinical Endocrinology & Metabolism, Vol 56, 673-677, Copyright © 1983 by Endocrine Society

ARTICLES

Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture

WB Malarkey, M Kennedy, LE Allred and G Milo

There is only indirect evidence at present to suggest a role for PRL in either the genesis or progression of human breast cancer. Here, we report the results of experiments in primary cultures of breast tumor cells from a hyperprolactinemic breast cancer patient who had an elevated mean 24-h PRL concentration but a normal diurnal variation of PRL release. The effects of PRL and GH on the growth of the dispersed cells from the breast tumor was evaluated in monolayer culture using a recently developed microculture technique. Pharmacological quantities of GH produced significant increases in the number of population doublings of the breast tumor cells. Also, PRL concentrations present in the patient's circulation were demonstrated to significantly increase the number of population doublings of the breast tumor cells obtained in primary cultures. Thus, physiological concentrations of PRL stimulated the growth of breast tumor cells from this premenopausal patient.

This article has been cited by other articles:

				L. M. Neilson, J. Zhu, J. Xie, M. G. Malabarba, K. Sakamoto, K.-U. Wagner, R. A. Kirken, and H. Rui Coactivation of Janus Tyrosine Kinase (Jak)1 Positively Modulates Prolactin-Jak2 Signaling in Breast Cancer: Recruitment of ERK and Signal Transducer and Activator of Transcription (Stat)3 and Enhancement of Akt and Stat5a/b Pathways Mol. Endocrinol., September 1, 2007; 21(9): 2218 - 2232. [Abstract] [Full Text] [PDF]

				M. H. Weinberger John Arthur Luetscher, Jr (1913-2005) Hypertension, April 1, 2006; 47(4): 627 - 628. [Full Text] [PDF]

				J. B. Kline, D. J. Moore, and C. V. Clevenger Activation and Association of the Tec Tyrosine Kinase with the Human Prolactin Receptor: Mapping of a Tec/Vav1-Receptor Binding Site Mol. Endocrinol., May 1, 2001; 15(5): 832 - 841. [Abstract] [Full Text]

				S. E. Hankinson, W. C. Willett, D. S. Michaud, J. E. Manson, G. A. Colditz, C. Longcope, B. Rosner, and F. E. Speizer Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women J Natl Cancer Inst, April 7, 1999; 91(7): 629 - 634. [Abstract] [Full Text] [PDF]

				T.-J. Chen, C. B. Kuo, K. F. Tsai, J.-W. Liu, D.-Y. Chen, and A. M. Walker Development of Recombinant Human Prolactin Receptor Antagonists by Molecular Mimicry of the Phosphorylated Hormone Endocrinology, February 1, 1998; 139(2): 609 - 616. [Abstract] [Full Text] [PDF]

				C. Reynolds, K. T. Montone, C. M. Powell, J. E. Tomaszewski, and C. V. Clevenger Expression of Prolactin and Its Receptor in Human Breast Carcinoma Endocrinology, December 1, 1997; 138(12): 5555 - 5560. [Abstract] [Full Text] [PDF]

				C. J. Ormandy, R. E. Hall, D. L. Manning, J. F. R. Robertson, R. W. Blamey, P. A. Kelly, R. I. Nicholson, and R. L. Sutherland Coexpression and Cross-Regulation of the Prolactin Receptor and Sex Steroid Hormone Receptors in Breast Cancer J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3692 - 3699. [Abstract] [Full Text] [PDF]